Health & Fitness
Health and Fitness
Health and Fitness
Tue, April 3, 2012Mon, April 2, 2012Sun, April 1, 2012Sat, March 31, 2012Fri, March 30, 2012Thu, March 29, 2012Wed, March 28, 2012Tue, March 27, 2012Mon, March 26, 2012Sun, March 25, 2012Sat, March 24, 2012Fri, March 23, 2012Thu, March 22, 2012Wed, March 21, 2012Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
Published in Health and Fitness on Wednesday, March 28th 2012 at 5:06 GMT by Market Wire
Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference -- SAN DIEGO, March 28, 2012 /PRNewswire/ --
Optimer Pharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
SAN DIEGO, March 28, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: [ OPTR ]) today announced that the Company will present at the 11th Annual Needham Healthcare Conference on Tuesday, April 3 at 3:20 p.m. Eastern Time in New York, NY.
(Logo: [ http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ])
A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at [ www.optimerpharma.com ]. Replays of the presentation will be available at the same location for 90 days following the presentation.
About Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed and commercialized DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD). Optimer has also received marketing authorization for fidaxomicin tablets in the European Union under the trade name DIFICLIR™. The company is seeking marketing authorization for fidaxomicin in Canada and is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem, including Asia. Additional information can be found at [ http://www.optimerpharma.com ].
Contacts
Optimer Pharmaceuticals, Inc.
David Walsey, VP of Investor Relations and Corporate Communications
858-909-0736
[ Dwalsey@optimerpharma.com ]
Canale Communications
Jason I. Spark, Senior Vice President
619-849-6005
[ Jason@canalecomm.com ]
SOURCE Optimer Pharmaceuticals, Inc.
[ Back to top ] RELATED LINKS
[ http://www.optimerpharma.com ]
